ArticleFrontiers in oncology2023

Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC.

Umberto Malapelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.